- Research
- Open access
- Published:
The new phthalic acid-based deep eutectic solvent as a versatile catalyst for the synthesis of pyrimido[4,5-d]pyrimidines and pyrano[3,2-c]chromenes
BMC Chemistry volume 18, Article number: 120 (2024)
Abstract
A new DES (MTPPBr-PHTH-DES) was prepared from a mixture of methyltriphenyl-phosphonium bromide (MTPPBr) and phthalic acid (PHTH). The eutectic point phase diagram showed that a one-to-one molar ratio of MTPPBr to PHTH is the optimal molar ratio for the synthesis of new DES. Then, it was characterized with various techniques such as FT-IR, TGA/DTA, densitometer, eutectic point, and NMR and used as a novel acid catalyst in the synthesis of pyrimido[4,5-d]pyrimidines and pyrano[3,2-c]chromes in solvent-free condition. Short reaction time, low temperature, high efficiency, green condition, and easy recycling and separation of the DES catalyst are among the most important features of the presented method.
Introduction
The importance of environmental protection has recently been seriously emphasized, and green chemistry has followed a smooth path to achieving these goals. Targeted use of solvents and catalysts is a fundamental solution to pursue environmental goals [1, 2]. Green environment solvents must meet various criteria such as availability, non-toxicity, recyclability, thermal stability, renewable ability, non-flammability, low vapor pressure, economy, and biodegradability [3, 4].
DESs have been developed in line with the goals of green chemistry as a suitable alternative to ionic liquids (ILs) and have found many applications in various research fields [5]. DESs are often cheap and safe and usually consist of mixing two or three ionic compounds where each component has a high melting point, but when they are combined, the melting point of the prepared DES is lower than either component [6,7,8]. DESs have countless advantages over conventional solvents, as they not only comply with the principles of green chemistry but also act as catalysts, depending on their properties and they do not need to be separated and purified. The use of DESs as acid catalysts has several advantages, including nontoxicity, catalytic efficiency comparable to or better than that of the acid itself, and the possibility of recovery and reuse without significant loss of activity [9,10,11].
A multicomponent reaction (MCR) is a reaction in which three or more reagents are added simultaneously to a reaction flask and mixed in a one-pot process. These reactions have several advantages over conventional synthesis protocols, including fewer steps, and no need to separate reaction intermediates, resulting in fewer purification steps. Since most of the carbon atoms are present in the final product, MCR can be considered as a good atom-economical process [12,13,14].
Since pyrimidine moieties are present in the structure of many natural compounds, they have been studied for more than a century for their chemical and biological importance, including anti-oxidant, anti-inflammatory, immunomodulatory, anti-bacterial, anti-viral, anti-hypertensive, anti-cancer, anti-thyroid, anti-parasitic, anti-malarial, anti-HIV, anti-viral, antifungal, anti-Leishmania, anti-HCV, anti-tumor, and urease inhibitory activities [15,16,17,18,19,20,21,22,23,24,25,26].
Below are some compounds that have a pyrimidine ring in their structure and are used in medicine. For example, Minoxidil acts directly on the smooth muscles of the vascular wall and reduces peripheral vascular resistance and blood pressure [27]. Cytarabine is easily converted into nucleotides inside the cells, inhibits DNA synthesis, and has a strong effect of suppressing the immune system and anticancer [22]. Propylthiouracil inhibits the synthesis of thyroid hormones and has antithyroid activity [23]. Primethamine has anti-infective and anti-malarial activity [24]. Lamivudine is an antiseptic drug and is used for HIV infections [25]. Trimethoprim is an antibiotic with a wide application range, which is used in the treatment of infections, especially urinary infections [25]. (Scheme 1).
Barbituric acids (BAs) are an important class of pyrimidines that have many medicinal uses and are used as hypnotics, sedatives, anti-convulsant, anesthetics, and anti-fungal. The most commonly used barbiturate drugs include butalbital, phenobarbital, barbital, and thialbarbital, and multicomponent reactions are the good method for the synthesis of heterocyclic compounds. High efficiency, short reaction time, energy saving, and simple operation are the advantages of multicomponent reactions [28,29,30,31].
Chromenes are an important group of heterocyclic compounds that are the result of the fusion of a benzene ring with a pyran ring. As an important class of compounds, they are widely present in plants, including edible vegetables and fruits, and as drugs have significant effects, including anticancer, anti-HIV, antiviral, anticoagulant, anti-anaphylaxis, spasmolytic, and diuretic [32,33,34,35,36,37] (Scheme 2).
Continuing our research on the preparation of novel catalytic systems, we would like to report here the preparation and characterization of the novel DES (3) by mixing one mole of MTPPBr (1) and one mole of PHTH (2) (Scheme 3).
Then, it was used as a novel DES catalyst in the synthesis of two sets of the following compounds at 70 °C in solvent‐free condition:
-
Pyrimido[4,5-d]pyrimidines 4(a–p) from the reaction of aldehydes (1), BA (2), urea (3), and
-
Pyrano[3,2-c]chromenes 7(a–j) from the reaction of 4-hydroxycoumarin (5), malononitrile (6), and aldehydes (1) (Scheme 4).
Results and discussion
Characterization of MTPPBr-PHTH-DES
The new DES was characterized by FT-IR, 1H NMR TGA-DTA, densitometer, and eutectic points.
Characterization by FT-IR
Figure 1 shows the IR spectra of MTPP-Br (a), PHTH (b), the fresh DES (c), and the recovered DES (d). In spectrum (a), the peaks at about 2900–3100 cm−1 are related to the aromatic and aliphatic hydrogens, and the peaks at about 750 and 1480 cm−1 are related to the C-P bonds, respectively. In spectrum (b), the peak in1700 cm−1 is related to the C=O group, and the broad peak in the region of 2400–3100 cm−1 is related to the OH of COOH. In spectrum (c), the indicated peaks can be seen in both (a) and (b) spectra, which confirm the structure of the DES catalyst.
To confirm the structure of the recovered DES (d), the corresponding IR spectrum was obtained which shows that there is no significant difference between the fresh (c) and the recovered IR spectra.
Characterization by 1H NMR
The 1H NMR spectrum of MTPPBr
Figure 2 shows the 1H NMR spectrum of MTPPBr. Peaks at 3.18–3.24 (d, 3H), and 7.79–7.63 (m, 15H) ppm are related to the CH3 hydrogens, and the three phenyl ring hydrogens of MTPPBr, respectively.
The 1H NMR spectrum of PHTH
Figure 3 shows the 1H NMR spectrum of PHTH. The peak at 13.04 (s, 1H) belongs to a hydrogen of the –COOH group. The peaks at 7.52–7.54 (d, 2H) and 7.61–7.63 (d, 2H) ppm are related to the four hydrogens of a phenyl ring.
The 1H NMR spectrum of MTPPBr-PHTH-DES
Figure 4 shows the 1H NMR spectrum of MTPPBr-PHTH-DES. Peaks at 3.10–3.13 (d, 3H), 7.71 (dt, J = 10.0, 3.7 Hz, 15H), 7.61 (dq, J = 7.9, 4.1 Hz, 2H), 7.53 (dt, J = 5.9, 3.6 Hz, 2H) and 13.05 (s, 2H) ppm are related to the CH3 hydrogens, three phenyl ring hydrogens, the phenyl ring of PHTH, and the acid groups, respectively. When DES is formed, the signal intensity of hydrogens weakens and shifts towards the low field. These observations indicate the presence of the new hydrogen bond interactions between MTPPBr and PHTH [38], confirming the structure of the newly formed DES.
Characterization by TGA-DTA
To investigate the stability and thermal behavior of the new DES, the TGA-DTA analysis was performed which shows three breaks (Fig. 5). The first failure in the area below 200 °C is related to the absorbed vapors during preparation of the catalyst. The second break in the area below 400 °C is probably related to the breaking of hydrogen bonds in the DES structure and removal of the acidic group, and the break at 600 °C is related to the decomposition of MTPPBr.
Characterization by densitometer
DESs usually have a density of 1.0 to 1.35 g/cm3, so a certain weight of DES was mixed with a certain volume of water, and its density was calculated using the relevant formula, which is about 1.33013 g/ml [39].
Characterization by eutectic points
To check the best ratio of MTPPBr to PHTH, the eutectic point experiment was performed, and different ratios of MTPPBr to PTHT were prepared. The eutectic point phase diagram (Fig. 6) showed that the best ratio for the novel DES formation is one mole of MTPPBr to one mole of PHTH.
The melting points of MTPPBr and PHTH are 230 and 210 °C, respectively, but when a novel DES was prepared, its melting point decreased to 60 °C.
Optimization of the reaction conditions for the synthesis of 4h
To check the performance of the catalyst to find the appropriate solvent (H2O, EtOH, H2O/EtOH, EtOAc, n-hexane, and solvent-free condition), temperature (50, 60, 70, 80, 90, and 100 °C), and amount of the catalyst (0.25, 0.5, 0.75, 1.0, 1.25, and 1.5 mol), the reaction between 4-chloro-benzaldehyde (1), BA (2), urea (3), and was chosen as a model reaction for the synthesis of 4h (Scheme 5).
The best result was found to be the 1:1:1 molar ratio of BA, urea, and 4-chloro-benzaldehyde with 1.0 mmol of the novel DES catalyst at 70 °C in solvent-free condition (Table 1).
Synthesis of 4(a–p)
Based on the obtained results from the model reaction, pyrimido[4,5-d]pyrimidines were synthesized under optimal reaction condition (Table 2). Short reaction times and high yields are important features of the proposed method.
Proposed mechanism for the synthesis of 4(a–p)
The possible mechanism for the synthesis of 4(a–p) is shown in Scheme 6. First, the carbonyl group of an aldehyde is activated by the DES catalyst to be susceptible to the nucleophilic attack of BA to form (I). By removing water, (II) will be formed, and its condensation with urea yields (III). Then, by internal cyclization of (III) and removing water, the final product (IV) is formed.
Reusability of DES in synthesis of 4(a–p)
Catalyst reusability and recovery is an essential parameter to be considered. Therefore, after completion of the reaction (TLC) under optimal condition, it was stopped, and the resulting mixture was washed with ethanol to separate the catalyst. Ethanol was removed from the filtrate and the separated DES was dried and used in further four reaction runs. The efficiency of reactions was about 92, 90, 86 and 79%, respectively which confirms the stability of the prepared DES catalyst (Fig. 7).
Comparison of the catalyst activities
Table 3 shows the comparison of different methods for the synthesis of 4(a–p). Green condition, short reaction time, low temperature, easy separation of the DES catalyst and high efficiency are the advantages of our proposed method.
Optimization of the reaction conditions for the synthesis of 7c
To check the performance of the catalyst to find an appropriate solvent (H2O, EtOH, H2O/EtOH, EtOAc, n-hexane, and solvent-free condition), temperature (50, 60, 70, 80, 90, and 100 °C), and amount of the catalyst (0.25, 0.5, 0.75, 1.0 1.25, and 1.5 mol), the reaction between 4-chlorobenzaldehyde (1), 4-hydroxy-coumarin (5), and malononitrile (6), was chosen as a model reaction for the synthesis of 3c (Scheme 7).
The best result was found to be the 1:1:1 mol ratio of BA, urea, and 4-chloro-benzaldehyde with 1.0 mmol of the novel DES catalyst at 60 °C in solvent-free condition (Table 4).
Synthesis of 7(a–j)
Table 5 shows the synthesis of diverse pyrano[3,2-c]chromenes under optimal condition in short reaction times and high yields.
Proposed mechanism for the synthesis of pyrano[3,2-c]chromenes
The possible mechanism for the synthesis of 7(a–j) is shown in Scheme 8. First, the carbonyl group of an aldehyde is activated by the DES catalyst to be susceptible to the nucleophilic attack of malononitrile to form (I). By removing water, (II) will be formed which condenses with 4-hydroxy-coumarin to yield (III). Then, by internal cyclization of (III), (IV) is formed, and the final product (V) will be formed by rearrangement of (IV).
Reusability of DES in the synthesis of pyrano[3,2-c]chromenes
After completion of the reaction (TLC) under optimal condition, it was stopped, and the resulting mixture was washed with ethanol to separate the catalyst. Ethanol was removed from the filtrate and the separated DES was dried and used in further four reaction runs. The efficiency of reactions was about 96, 95, 91 and 88%, respectively which confirms the stability of the prepared DES catalyst (Fig. 8).
Comparison of the catalyst activities
Table 6 shows the comparison of different methods for the synthesis of 7(a–j). Green condition, short reaction time, low temperature, easy separation of the DES catalyst and high efficiency are the advantages of our proposed method.
Experimental section
Materials and methods
All chemicals were provided by the foreign chemical companies and used as received. Progress of the reactions was monitored by the TLC-silica gel 60 F-254 plates. The Fourier Transform Infrared (FT-IR) spectra were recorded by the Perkin-Elmer Spectrum Version 10.02.00 using KBr pellets. The NMR spectra were recorded on a 250 MHz Bruker spectrometer. Melting points were determined on a BUCHI 510 melting point apparatus. The density of the DES catalyst was determined by the AND-HR200 instrument. Thermo-Gravimetric-Analysis Differential-Thermal-Analysis (TGA-DTA) was done by the SDT-Q600 device.
General procedure for preparation of MTPPBr-PHTH-DES
The mixture of MTPPBr and PHTH (molar ratio 1:1) was stirred at 60 °C in solvent-free condition until a homogeneous liquid was obtained. When it was cooled slowly at room temperature, it turned into a transparent solid (DES) which dissolves well in water or ethanol.
General procedure for the synthesis of pyrimido[4,5-d]pyrimidines 4(a–p)
BA (1 mmol, 128 mg), urea (1 mmol, 60.06 mg), aldehyde (1.0 mmol), and DES catalyst (1 mmol, 0.523 g) were mixed and stirred at 70 °C in solvent‐free condition for an appropriate time. After completion of the reaction (TLC), the resulting mixture was washed with ethanol to separate the catalyst (the DES catalyst is soluble in ethanol and the reaction mixture is insoluble). Ethanol was removed from the filtrate and the separated DES was kept for further reactions.
A solid precipitate was washed several times with ethanol and characterized with comparison of their FT-IR, 1 HNMR, 13C NMR, Mass spectra, and melting points with authentic samples.
Spectral data of the 4(a–p)
5-(4-Isopropylphenyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,6H)-trione (4a)
Yellow solid, M.P.: 228–230 °C; IR (KBr) ν = 3202, 3089, 2957, 2868, 1751, 1703, 1673, 1578, 1440, 1414, 1343, 1307, 1212, 1196, 1136, 1077, 1045, 1021, 837, 813, 794, 634 and 545 cm−1. 1H NMR (250 MHz, DMSO-d6) δ = 11.34 (s, 1H), 11.19 (s, 1H), 8.24 (s, 1H), 7.72 (dd, J = 187.4, 7.9 Hz, 5H), 5.47 (s, 1H). 2.93 (h, J = 6.7 Hz, 1H), 1.21 (d, J = 6.8 Hz, 6H). 13C NMR (62.5 MHz, DMSO-d6) δ = 164.0, 162.2, 155.3, 154.3, 150.6, 134.5, 133.7, 130.7, 126.6, 125.6, 124.8, 118.3, 34.0, 32.0, 26.6, 23.8.
4-(2,5,7-Trioxo-1,2,3,4,5,6,7,8-octahydropyrimido[4,5-d]pyrimidin-4-yl)benzoic acid (4b)
Yellow solid, M.P.: 296–300 °C; IR (KBr) ν = 3271, 3247, 3131, 2874, 1777, 1766, 1734, 1705, 1599, 1417, 1366, 1322, 1289, 1252, 1218, 1059, 1041, 966, 772, 744, 685 and 502 cm−1. 1H NMR (250 MHz, DMSO-d6) δ = 11.57 (s, 1H), 11.47–11.18 (m, 2H), 10.98–10.81 (m, 2H), 7.85–7.81 (m, 2H), 7.73–7.69 (m, 1H), 7.54–7.52 (m, 1H), 6.23 (s, 1H). 13C NMR (62.5 MHz, DMSO-d6) δ = 169.5, 162.7, 150.8, 134.5, 134.4, 133.3, 129.4, 129.4, 127.5, 125.5, 123.2, 78.9, 51.1. MS: m/z = 302.1 [M]+, Base peak: m/z = 231.2.
5-(4-(Diethylamino)phenyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,6H)-trione (4c)
Yellow solid, M.P.: 217–220 °C; IR (KBr) ν = 3445, 3271, 3208, 3027, 1736, 1684, 1652, 1608, 1449, 1443, 1391, 1345, 1311, 1187, 1153, 1075, 1011, 795, 677 and 518 cm−1. 1H NMR (250 MHz, DMSO-d6) δ = 11.04 (s, 1H), 10.91 (s, 1H), 8.41 (s, 1H), 8.11 (s, 1H), 7.80–5.86 (m, 4H), 5.44 (s, 1H), 3.49–3.42 (m, 4H), 1.12 (t, J = 7.6 Hz, 6H).13C NMR (62.5 MHz, DMSO-d6) δ = 165.2, 165.2, 163.2, 160.1, 155.7, 155.7, 152.6, 150.8, 142.8, 139.9, 120.1, 111.3, 111.3, 109.3, 44.6, 12.9.; MS: m/z = 329.2 [M]+, Base peak: m/z = 272.1.
5-(3-Ethoxy-4-hydroxyphenyl)-5,8-dihydropyrimido[4,5-d]pyrimidine2,4,7(1H,3H,6H)-trione (4d)
Yellow solid, M.P.: 257–259 °C; IR (KBr) ν = 3512, 3205, 3039, 2842, 1761, 1701, 1652, 1543, 1505,1405, 1349, 1277, 981, 793, 753, 513 and 407 cm−1. 1H NMR (250 MHz, DMSO-d6) δ = 11.22 (d, J = 6.9 Hz, 1H), 11.10 (d, J = 6.8 Hz, 1H), 10.45 (d, J = 7.3 Hz, 1H), 8.46 (d, J = 5.9 Hz, 1H), 8.18 (d, J = 7.6 Hz, 1H), 7.76–6.83 (m, 3H), 5.39 (s, 1H), 4.09–4.03 (m, 2H), 1.38–1.32 (m, 3H). 13C NMR (62.5 MHz, DMSO-d6) δ = 165.1, 164.6, 162.9, 156.4, 153.7, 150.6, 146.5, 132.9, 124.6, 119.4, 115.8, 114.3, 64.2, 15.0.; MS: m/z = 318.2 [M]+, Base peak: m/z = 276.1.
5-(2,3-Dihydroxyphenyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,6H)-trione (4e)
Yellow solid, M.P.: 223–225 °C; IR (KBr) ν = 3600, 3438, 3361, 3223, 3096, 1748, 1712, 1635, 1474, 1456, 1347, 1216, 1149, 845, 781, 496 and 419 cm−1. 1H NMR (250 MHz, DMSO-d6) δ = 11.89 (s, 1H), 11.24 (s, 1H), 11.15–11.08 (m, 1H), 10.95 (s, 1H), 10.12–10.00 (m, 1H), 7.00–6.79 (m, 2H), 6.50 (d, J = 7.3 Hz, 1H), 5.42 (s, 1H), 4.64 (s, 1H). 13C NMR (62.5 MHz, DMSO-d6) δ = 164.0, 160.1, 151.0, 149.9, 145.9, 138.4, 125.6, 122.2, 117.7, 116.1, 85.5, 53.5.; MS: m/z = 290.1 [M]+, Base peak: m/z = 230.
5-Phenyl-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,6H)-trione (4f)
Yellow solid, M.P.: 262–265 °C; IR (KBr) ν = 3215, 3069, 2836, 1743, 1677, 1582, 1566, 1451, 1405, 1341, 1297, 1203, 1033, 864, 763, 680, 526 and 419 cm−1.
5-(2-Chlorophenyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,6H)-trione (4g)
Yellow solid, M.P.: 215–218 °C; IR (KBr) ν = 3487, 3450, 3210, 3051, 2819, 1766, 1678, 1611, 1431, 1383, 1275, 1228, 1049, 943, 806, 789, 754, 609, 525, 505, and 435 cm−1.
5-(4-Chlorophenyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,6H)-trione (4h)
Yellow solid, M.P.: 297–300 °C; IR (KBr) ν = 3212, 3087, 2845, 1755, 1704, 1673, 1574, 1554, 1443, 1413, 1344, 1289, 1202, 1092, 1019, 882, 838, 809, 793, 550 and 423 cm−1.
5-(2,4-Dichlorophenyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,6H)-trione (4i)
Yellow solid, M.P.: 270–273 °C; IR (KBr) ν = 3211, 3074, 2832, 1759, 1722, 1691, 1578, 1439, 1379, 791 and 509 cm−1.
5-(3-Nitrophenyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,6H)-trione (4j)
Yellow solid, M.P.: 247–250 °C; IR (KBr) ν = 3409, 3083, 2963, 2778, 1755, 1725, 1688, 1650, 1526, 1409, 1380, 1352, 1246, 1218, 1080, 1009, 909, 843, 809, 728, 499 and 417 cm−1.
5-(4-Nitrophenyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,6H)-trione (4k)
Yellow solid, M.P.: 246–249 °C; IR (KBr) ν = 3343, 3269, 3078, 2995, 2837, 1721, 1650, 1519, 1419, 1379, 1349, 1292, 1238, 1109, 1013, 860, 778, 697, 657, 550 and 534 cm−1.
5-(p-Tolyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,6H)-trione (4l)
Yellow solid, M.P.: 270–275 °C; IR (KBr) ν = 3467, 3210, 3081, 2839, 1752, 1675, 1556, 1430, 1344, 1296, 1192, 822, and 523 cm−1.
5-(4-Methoxyphenyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,6H)-trione (4m)
Yellow solid, M.P.: 297–300 °C; IR (KBr) ν = 3208, 3070, 2841, 1729, 1673, 1550, 1508, 1435, 1401, 1308, 1271, 1180, 1015, 837, 794, 628, 519 and 421 cm−1.
5-(3,4-Dimethoxyphenyl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,6H)-trione (4n)
Yellow solid, M.P.: 320–324 °C; IR (KBr) ν = 3226, 3146, 3076, 2950, 1740, 1696, 1655, 1541, 1496, 1424, 1390, 1276, 1148, 1011, 798, 524 and 483 (cm−1).
5-(Furan-2-yl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,6H)-trione (4o)
Yellow solid, M.P.: 323–325 °C; IR (KBr) ν = 3512, 3205, 3121, 3037, 2842, 1741, 1761, 1698, 1651, 1543, 1499, 1441, 1276, 1163, 972, 793, 753, and 515 (cm−1).
5-(Thiophen-2-yl)-5,8-dihydropyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,6H)-trione (4p)
Yellow solid, M.P.: 330–333 °C; IR (KBr) ν = 3226, 3146, 3076, 2950, 1740, 1696, 1655, 1541, 1496, 1424, 1390, 1276, 1148, 1011, 798, 524 and 483 (cm−1).
General procedure for the synthesis of pyrano[3,2-c]chromenes 7(a–j)
4-Hydroxycoumarin (1 mmol, 162 mg), malononitrile (1 mmol, 66 mg), aldehyde (1.0 mmol), and the DES catalyst (1 mmol, 0.523 mg) were mixed and stirred at 70 °C in solvent‐free condition for an appropriate time. After completion of the reaction (TLC), the resulting mixture was washed with ethanol to separate the catalyst (the DES catalyst is soluble in ethanol and the reaction mixture is insoluble). Ethanol was removed from the filtrate and the separated DES was kept for further reactions.
A solid precipitate was washed several times with ethanol and characterized with comparison of their FT-IR, 1HNMR spectra, and melting points with authentic samples.
Spectral data of the 7(a–j)
2-Amino-5-oxo-4-phenyl-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile (7a)
White solid, M.P.: 228–230 °C; IR (KBr) ν = 3376, 3285, 3065, 2198, 1709, 1675, 1605, 1638, 1382, 1211, 1113, 1058, 956, 758, 706 and 522 (cm−1).
2-Amino-4-(2-chlorophenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile (7b)
White solid, M.P.: 228–230 °C; IR (KBr) ν = 3402, 3284, 3180, 3086, 2192, 1710, 1675, 1602, 1458, 1382, 1174, 1063, 958, 904, 756 and 522. (cm−1).
2-Amino-4-(4-chlorophenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile (7c)
White solid, M.P.: 228–230 °C; IR (KBr) ν = 3382, 3307, 3291, 2193, 1714, 1676, 1603, 1562, 1458, 1378, 1213, 1092, 1061, 906, 845, 765 and 513 (cm−1).
2-Amino-4-(2,4-dichlorophenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile (7d)
White solid, M.P.: 228–230 °C; IR (KBr) ν = 3323, 3204, 2195, 1720, 1668, 1601, 1512, 1381, 1264, 1143, 1095, 762 and 481 (cm−1).
2-Amino-4-(3-nitrophenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile (7e)
White solid, M.P.: 228–230 °C; IR (KBr) ν = 3322, 3193, 3093, 2994, 2203, 1703, 1672, 1606, 1531, 1381, 1347, 1176, 1058, 898, 762 and 709 (cm−1).
2-Amino-4-(4-nitrophenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile (7f)
White solid, M.P.: 228–230 °C; IR (KBr) ν = 3369, 3335, 3073, 2195, 1717, 1671, 1606, 1505, 1347, 1370, 1055, 765 and 459 (cm−1).
2-Amino-4-(3,4-dimethoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile (7g)
White solid, M.P.: 234–236 °C; IR (KBr) ν = 3406, 3326, 3261, 2196, 1709, 1673, 1378, 1048 and 760. 1H NMR (250 MHz, DMSO-d6) δ = 7.87 (d, J = 7.8 Hz, 1H), 7.68 (t, J = 7.8 Hz, 1H), 7.45 (t, J = 9.3 Hz, 2H), 7.35 (s, 2H), 6.85 (d, J = 12.4 Hz, 2H), 6.72 (d, J = 8.3 Hz, 1H), 4.38 (s, 1H), 3.69 (s, 6H). 13C NMR (62.5 MHz, DMSO-d6) δ = 158.4, 152.5, 149, 149, 136.3, 133.3, 125.1, 122.9, 120.1, 119.8, 117, 112.3, 112, 104.5, 58.5, 55.9, 40.9, 40.6, 40.3, 39.9, 39.6, 39.3, 38.9, 36.9.
2-Amino-4-(4-isopropylphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile (7h)
White solid, M.P.: 230–233 °C; IR (KBr) ν = 3390, 3304, 3205, 2202, 1713, 1672, 1375, 1050 and 769. (cm−1).
2-Amino-4-(4-hydroxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile (7i)
White solid, M.P.: 228–230 °C; IR (KBr) ν = 3504, 3410, 3287, 3184, 3068, 2879, 2197, 1697, 1674, 1610, 1513, 1460, 1382, 1266, 1071, 844, 760, 562 and 524 (cm−1).
2-Amino-5-oxo-4-(thiophen-2-yl)-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile (7j)
White solid, M.P.: 228–230 °C; IR (KBr) ν = 3368, 3279, 3177, 3070, 2200, 1709, 1668, 1601, 1564, 1308, 1056, 760 and 705 (cm−1).
Conclusion
In conclusion, the new DES (MTPPBr-PHTH-DES) was prepared, characterized and used as a novel catalyst in the synthesis of pyrimido[4,5-d]pyrimidines 4(a–p) and pyrano[3,2-c]chromenes 7(a–j). The newly synthesized DES catalyst can be synthesized simply by mixing and heating the starting materials, which does not require any additional purification steps, and a simple filtration is sufficient to separate it from the reaction mixture. It can be used not only as a moderate, inexpensive, and environmentally safe solvent, but also as recyclable and reusable organocatalyst to facilitate organic transformations.
Availability of data and materials
All the methods carried out in this project are in accordance with relevant local/national/ international institutional guidelines and regulations. All data generated or analyzed during this study are not publicly available due to DATA NOT PUBLIC but are available from the corresponding author on reasonable request.
References
Mukherjee P. Green chemistry—a novel approach towards sustainability. J Chil Chem Soc. 2018;66:5075–80.
Anastas P, Eghbali N. Green chemistry: principles and practice. Chem Soc Rev. 2010;39(1):301–12.
Constable DJ, Curzons AD, Cunningham VL. Metrics to green chemistry which are the best? Green Chem. 2002;4(6):521–7.
Monem A, Habibi D, Goudarzi H. An acid-based DES as a novel catalyst for the synthesis of pyranopyrimidines. Sci Rep. 2023;13(1):18009.
Płotka-Wasylka J, et al. Deep eutectic solvents vs ionic liquids: Similarities and differences. Microchem J. 2020;159:105539.
Mohammadi M, et al. Targeted development of sustainable green catalysts for oxidation of alcohols via tungstate-decorated multifunctional amphiphilic carbon quantum dots. ACS Appl Mater Inter. 2019;11(36):33194–206.
Makone SS, Niwadange SN. Green chemistry alternatives for sustainable development in organic synthesis. Green Chem. 2016;3:113–5.
Rahmati M, Habibi D. Synthesis of a novel acidic ionic liquid catalyst and its application for preparation of pyridines via a cooperative vinylogous anomeric-based oxidation. Res Chem Intermed. 2021;47:1643–61.
Abbott AP, et al. Preparation of novel, moisture-stable, Lewis-acidic ionic liquids containing quaternary ammonium salts with functional side chains Electronic supplementary information (ESI) available: plot of conductivity vs. temperature for the ionic liquid formed from zinc chloride and choline chloride (2∶1). Chem Commun. 2001;19:2010–1.
Monem A, Habibi D, Goudarzi H. The novel catalyst (hypogallic acid-based DES) for preparation of the new compounds (pyrano[2,3-d]pyrimidines). Polycycl Aromat Compd. 2023. https://doiorg.publicaciones.saludcastillayleon.es/10.1080/10406638.2023.2254900.
Oguche J, et al. Prospect of deep eutectic solvents in lactic acid production process: a review. Chem Rev. 2023;5(2):96–128.
Ramazani A, Reza KA. Preparation of stabilized phosphorus ylides via multicomponent reactions and their synthetic applications. Curr Org Chem. 2011;15(23):3986–4020.
Kalantari F, Rezayati S, Ramazani A, Poor HM. Syntheses, and structures of magnetic nanodendrimers and their catalytic application in organic synthesis. Appl Organomet Chem. 2023;37(6): e7064.
Khoobi M, et al. Coumarin-based bioactive compounds: facile synthesis and biological evaluation of coumarin-fused 1, 4-thiazepines. Chem Biol Drug Des. 2011;78(4):580–6.
Mohamed H, et al. Computational studies and DFT calculations of synthesized triazolo pyrimidine derivatives: a review. Chem Rev. 2022;4(2):156–90.
Jadidi K, Ghahremanzadeh R, Bazgir A. Efficient synthesis of spiro[chromeno[2,3-d]-pyrimidine-5,3′-indoline]-tetraones by a one-pot three-component reaction. J Comb Chem. 2009;11(3):341–4.
Zhou D, et al. Synthesis and properties of aminopropyl nucleic acids. ChemBioChem. 2005;6(12):2298–304.
Sasaki T, et al. Syntheses, and properties of some pyrimidine 2,4ʹ-cyclo nucleosides. J Org Chem. 1975;40(1):106–11.
Kubota Y, et al. Synthesis, and fluorescence properties of pyrimidine mono-and bisboron complexes. J Org Chem. 2013;78(14):7058–67.
Lagoja IM. Pyrimidine as constituent of natural biologically active compounds. Chem Biodivers. 2005;2(1):1–50.
Song M, et al. Transformation performance and subsystem coupling of resource-based cities in China: an analysis based on the support-pressure framework. Integr Environ Assess Manag. 2022;18(3):770–83.
Hertel LW, et al. Synthesis of 2-deoxy2,2-difluoro-d-ribose and 2-deoxy-2,2ʹ-difluoro-d-ribofuranosyl nucleosides. J Org Chem. 1988;53(11):2406–9.
Anderson GW, et al. Studies in chemotherapy. X. Antithyroid compounds. Synthesis of 5- and 6-substituted 2-thio-uracils from β-oxoesters and thiourea1. J Am Chem Soc. 1945;67(12):2197–200.
Russell PB, Hitchings GH. Synthesis of 2-deoxy-2,2-difluoro-d-ribose and 2-de-oxy-2,2ʹ-difluoro-d-ribofuranosyl nucleosides. J Am Chem Soc. 1951;73:3763–70.
Lednicer D. Strategies for organic drug synthesis and design. Hoboken: John Wiley and Sons; 2009.
Jays J, Mohan S, Saravanan J. Molecular docking studies of novel aminopyrimidines as potent antifungal agents. Chem Methodol. 2019;3:442–50.
McCall J, TenBrink M, Ursprung RE. New approach to triaminopyrimidine N-oxide. J Org Chem. 1975;40(22):3304–6.
Rathee P, et al. Synthesis, and application of thio-barbituric acid derivatives as antifungal agents. Cell Mol Biol. 2016;62(140.10):1–5.
Mobinikhaledi A, Kalhor M. Synthesis and biological activity of some oxo- and thioxopyrimidines. Int J Drug Dev Res. 2010;2:268–72.
Mohamed NR, et al. Utility of 6-amino-2-thiouracil as a precursor for the synthesis of bioactive pyrimidines. Bioorg Med Chem. 2007;15(18):6227–35.
Mowlazadeh Haghighi S, et al. One pot synthesis of heterocyclic dihydroquinoline analogs incorporating quinoline and pyrimidine fused rings in condensation reaction using NCTDSS as a catalyst. Asian J Green Chem. 2022;6(3):203–22.
Moro AJ, et al. 2,2′-Spirobis[chromene] derivatives chemistry and their relation with the multistate system of anthocyanins. J Org Chem. 2017;82(10):5301–9.
Harbone JB. The flavonoids advances in research. London: Chapman and Hall; 1988. p. 19–134.
Iacobucci GA, Sweeny JG. The chemistry of anthocyanins, anthocyanidins and related flavylium salts. Tetrahedron. 1983;39(19):3005–38.
Polyakov VV. Chemical modification of the natural flavonoid myricetin. Chem Nat Compd. 1988;35:21–8.
Kamble R, et al. DTP/SiO2: an efficient and reusable heterogeneous catalyst for synthesis of dihydropyrano[3,2-c]chromene-3-carbonitrile derivatives. Appl Organo-met Chem. 2021;1:22–8.
Kiyani H, Ghorbani F. Potassium phthalimide promoted green multicomponent tandem synthesis of 2-amino-4H-chromenes and 6-amino-4H-pyran-3-carboxylates. J Saudi Chem Soc. 2014;18(5):689–701.
Chen W, et al. Tailoring hydrophobic deep eutectic solvent for selective lithium recovery from the mother liquor of Li2CO3. J Chem Eng. 2021;420:127648.
Wang H, et al. Ionic liquid analogous formed from magnesium chloride hexahydrate and its physicochemical properties. J Mol Liq. 2011;163(2):77–82.
Mobini-khaledi A, et al. High efficient synthesis of pyrimido[4,5-d]pyrimidines and adsorption of CO2 using a novel nanomaterial (MnCo Fe2O4@oval-bumin). Res Chem Intermed. 2023. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s11164-023-05042-2.
Yadollahi M, Hamadi H, Nobakht V. CoFe2O4/TMU-17-NH2 as a hybrid magnetic nano-composite catalyst for multicomponent synthesis of dihydropyrimidines. Appl Organomet Chem. 2019;3(1): e4629.
Gupta P, et al. One pot synthesis of spiro pyrimidinethiones/spiro pyrimidinones, quinazolinethiones/quinazolinones, and pyrimido-pyrimidines. J Heterocycl Chem. 2010;47(2):324–33.
Jadhav C, Khillare LD, Bhosle MR. Efficient sonochemical protocol for the facile synthesis of dipyrimido-dihydropyridine and pyrimido[4,5-d]pyrimidines in aqueous β-cyclo-dextrin. Synth Commun. 2018;48(3):233–46.
Alinezhad H, Pakzad K. Green synthesis of copper oxide nanoparticles with an extract of Euphorbia maculata and their use in the Biginelli reaction. Org Prep Proced Int. 2020;52(4):319–27.
Rostamizadeh S, et al. Dual acidic ionic liquid immobilized on α-Fe2O3–MCM-41 magnetic mesoporous materials as the hybrid acidic nanocatalyst for the synthesis of pyrimido[4,5-d]pyrimidine derivatives. Catal Lett. 2014;144:1772–83.
Abdolmohammadi S, Afsharpour M. An operationally simple green procedure for the synthesis of dihydropyrimido[4,5-d]pyrimidinetriones using CuI nanoparticles as a highly efficient catalyst. Zeitschrift für Naturforschung B. 2015;70(3):171–6.
Shirini F, et al. Preparation and characterization of [H2-DABCO][ClO4]2 as a new member of DABCO-based ionic liquids for the synthesis of pyrimido[4,5-b]quinoline and pyrimido[4,5-d]pyrimidine derivatives. J Mol Struct. 2018;1161:366–82.
Benrashid A, et al. The l-proline modified Zr-based MOF (Basu-proline) catalyst for the one-pot synthesis of dihydro-pyrano[3,2-c]chromenes. Sci Rep. 2023;13(1):1–16.
Niknam K, Jamali A. Silica-bonded N-propylpiperazine sodium n-propionate as recyclable basic catalyst for synthesis of 3,4-dihydropyrano[c]chromene derivatives and bis-coumarins. Chin J Catal. 2012;33(11–12):1840–9.
Mehrabi H, Kazemi-Mireki M. CuO nanoparticles: an efficient and recyclable nanocatalyst for the rapid and green synthesis of 3,4-dihydropyrano[c]chromenes. Chin Chem Lett. 2011;22(12):1419–22.
Abdolmohammadi S, Balalaie S. Novel, and efficient catalysts for the one-pot synthesis of 3,4-dihydropyrano[c]chromene derivatives in aqueous media. Tetrahedron Lett. 2007;48(18):3299–303.
Montaghami A, Montazeri N. An efficient method for the one-pot, three-component synthesis of 3,4-dihydropyrano[c]chromenes catalyzed by nano Al2O3. Orient J Chem. 2014;30(3):1361.
Mansoor SS, et al. An appropriate one-pot synthesis of 3,4-dihydropyrano[c]chromenes and 6-amino-5-cyano-4-aryl-2-methyl-4H-pyrans with thiourea dioxide as an efficient, reusable organic catalyst in aqueous medium. J Taibah Univ Sci. 2015;9(2):213–26.
Khurana JM, Nand B, Saluja P. DBU: a highly efficient catalyst for one-pot synthesis of substituted 3,4-dihydropyrano[3,2-c]chromenes, dihydropyrano[4,3-b]pyranes, 2-amino-4H-benzo[h]chromenes and 2-amino-4H-benzo[g]chromenes in aqueous medium. Tetrahedron. 2010;66(30):5637–41.
Heravi MM, et al. H5BW12O40 as a green and efficient homogeneous and recyclable catalyst in the synthesis of 4H-pyrans via multicomponent reaction. Appl Organomet Chem. 2018;32(9): e4479.
Jain S, et al. Solvent-free green and efficient one-pot synthesis of dihydropyrano[3,2-c]chromenes. ISRN Org Chem. 2013. https://doiorg.publicaciones.saludcastillayleon.es/10.1155/2013/185120.
Wang JH, Lu J, Zhang ZH. Highly efficient three-component one-pot synthesis of dihydropyrano[3,2-c]chromene derivatives. Monatsh Chem. 2010;141:1107–12.
Acknowledgements
The authors are grateful to the Bu-Ali Sina University for the support of this work.
Funding
This study was financially supported by the Bu-Ali Sina University, Hamedan Iran, and had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Author information
Authors and Affiliations
Contributions
Arezo Monem did the lab experiment. Davood Habibi wrote the main manuscript text. Hadis Goudarzi is a co-author. Abdolhamid Alizadeh is a co-author. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Monem, A., Habibi, D., Alizadeh, A. et al. The new phthalic acid-based deep eutectic solvent as a versatile catalyst for the synthesis of pyrimido[4,5-d]pyrimidines and pyrano[3,2-c]chromenes. BMC Chemistry 18, 120 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13065-024-01227-x
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13065-024-01227-x